VEGFA and diabetic macular edema: The effectiveness of anti VEGF therapies in patients with diabetic macular edema remains disputable [15] and suggests that other hypoxia-induced molecular factors may be involved such as PDGF, IGF-1, HGF, bFGF/FGF-2 [16].